Literature DB >> 23821548

RLIP76 protein knockdown attenuates obesity due to a high-fat diet.

Sharad S Singhal1, James Figarola, Jyotsana Singhal, Marpadga A Reddy, Xueli Liu, David Berz, Rama Natarajan, Sanjay Awasthi.   

Abstract

Feeding a Western high-fat diet (HFD) to C57BL/6 mice induces obesity, associated with a chronic inflammatory state, lipid transport, and metabolic derangements, and organ system effects that particularly prominent in the kidneys. Here, we report that RLIP76 homozygous knock-out (RLIP76(-/-)) mice are highly resistant to obesity as well as these other features of metabolic syndrome caused by HFD. The normal increase in pro-inflammatory and fibrotic markers associated with HFD induced obesity in wild-type C57B mice was broadly and nearly completely abrogated in RLIP76(-/-) mice. This is a particularly striking finding because chemical markers of oxidative stress including lipid hydroperoxides and alkenals were significantly higher in RLIP76(-/-) mice. Whereas HFD caused marked suppression of AMPK in wild-type C57B mice, RLIP76(-/-) mice had baseline activation of AMP-activated protein kinase, which was not further affected by HFD. The baseline renal function was reduced in RLIP76(-/-) mice as compared with wild-type, but was unaffected by HFD, in marked contrast to severe renal impairment and glomerulopathy in the wild-type mice given HFD. Our findings confirm a fundamental role of RLIP76 in regulating the function of obesity-promoting pro-inflammatory cytokines, and provide a novel mechanism for targeted therapy of obesity and metabolic syndrome.

Entities:  

Keywords:  Adiponectin; Adipose Tissue; Insulin; Kidney; Leptin; Obesity

Mesh:

Substances:

Year:  2013        PMID: 23821548      PMCID: PMC3743508          DOI: 10.1074/jbc.M113.480194

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  AN EPIDEMIOLOGICAL APPROACH TO OBESITY.

Authors:  F W NORDSIEK
Journal:  Am J Public Health Nations Health       Date:  1964-10

Review 2.  Selective insulin and leptin resistance in metabolic disorders.

Authors:  A Christine Könner; Jens C Brüning
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

3.  AMPK mediates the initiation of kidney disease induced by a high-fat diet.

Authors:  Anne-Emilie Declèves; Anna V Mathew; Robyn Cunard; Kumar Sharma
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

4.  Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition.

Authors:  Alexis E Malavazos; Massimiliano M Corsi; Federica Ermetici; Calin Coman; Francesco Sardanelli; Antonio Rossi; Lelio Morricone; Bruno Ambrosi
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-03-31       Impact factor: 4.222

5.  The Anti-Coronary Club: 1957 to 1972.

Authors:  H S Singman; S N Berman; C Cowell; E Maslansky; M Archer
Journal:  Am J Clin Nutr       Date:  1980-06       Impact factor: 7.045

6.  Alterations in peripheral blood lymphocyte cytokine expression in obesity.

Authors:  R W O'Rourke; T Kay; E A Lyle; S A Traxler; C W Deveney; B A Jobe; C T Roberts; D Marks; J T Rosenbaum
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

7.  Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis.

Authors:  Rana El-Bikai; Mélanie Welman; Yoran Margaron; Jean-François Côté; Luke Macqueen; Michael D Buschmann; Hassan Fahmi; Qin Shi; Karim Maghni; Julio C Fernandes; Mohamed Benderdour
Journal:  Arthritis Res Ther       Date:  2010-10-26       Impact factor: 5.156

8.  IL6 and IL1B polymorphisms are associated with fat mass in older men: the MrOS Study Sweden.

Authors:  Louise Strandberg; Dan Mellström; Osten Ljunggren; Elin Grundberg; Magnus K Karlsson; Anna H Holmberg; Eric S Orwoll; Anna L Eriksson; Johan Svedberg; Magnus Bengtsson; Claes Ohlsson; John-Olov Jansson
Journal:  Obesity (Silver Spring)       Date:  2008-01-17       Impact factor: 5.002

9.  RLIP76 in defense of radiation poisoning.

Authors:  Jyotsana Singhal; Sharad S Singhal; Sushma Yadav; Sumihiro Suzuki; Molly M Warnke; Adly Yacoub; Paul Dent; Sejong Bae; Rajendra Sharma; Yogesh C Awasthi; Daniel W Armstrong; Sanjay Awasthi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

10.  RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome.

Authors:  Jyotsana Singhal; Lokesh Nagaprashantha; Rit Vatsyayan; Sanjay Awasthi; Sharad S Singhal
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

View more
  14 in total

1.  Targeting RLIP with CRISPR/Cas9 controls tumor growth.

Authors:  Jyotsana Singhal; Shireen Chikara; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  Carcinogenesis       Date:  2021-02-11       Impact factor: 4.944

2.  Transcriptional and Epigenetic Response to Sedentary Behavior and Physical Activity in Children and Adolescents: A Systematic Review.

Authors:  Abel Plaza-Florido; Inmaculada Pérez-Prieto; Pablo Molina-Garcia; Shlomit Radom-Aizik; Francisco B Ortega; Signe Altmäe
Journal:  Front Pediatr       Date:  2022-06-24       Impact factor: 3.569

3.  Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES.

Authors:  Tatsuya Tominaga; Rajesh K Dutta; Darukeshwara Joladarashi; Toshio Doi; Janardan K Reddy; Yashpal S Kanwar
Journal:  J Biol Chem       Date:  2015-11-17       Impact factor: 5.157

4.  Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice.

Authors:  Sharad S Singhal; David Horne; Jyotsana Singhal; Steven Vonderfecht; Ravi Salgia; Sanjay Awasthi
Journal:  Mol Carcinog       Date:  2019-04-21       Impact factor: 4.784

5.  Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP.

Authors:  Jyotsana Singhal; Prakash Kulkarni; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  Mol Carcinog       Date:  2021-02-05       Impact factor: 4.784

Review 6.  Activating p53 function by targeting RLIP.

Authors:  Sharad S Singhal; David Horne; Jyotsana Singhal; Sanjay Awasthi; Ravi Salgia
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-01-15       Impact factor: 11.414

Review 7.  Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications.

Authors:  Byoung-Joon Song; Mohammed Akbar; Mohamed A Abdelmegeed; Kyunghee Byun; Bonghee Lee; Seung Kew Yoon; James P Hardwick
Journal:  Redox Biol       Date:  2014       Impact factor: 11.799

8.  2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.

Authors:  Jyotsana Singhal; Shireen Chikara; David Horne; Ravi Salgia; Sanjay Awasthi; Sharad S Singhal
Journal:  Mol Carcinog       Date:  2018-09-19       Impact factor: 4.784

9.  Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis.

Authors:  Sharda P Singh; Jihyun Lee; Chhanda Bose; Hongzhi Li; Yate-Ching Yuan; Ashly Hindle; Sharad S Singhal; Jonathan Kopel; Philip T Palade; Catherine Jones; Rakhshanda L Rahman; Sanjay Awasthi
Journal:  Cancers (Basel)       Date:  2021-07-02       Impact factor: 6.639

10.  2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.

Authors:  Lokesh Dalasanur Nagaprashantha; Jyotsana Singhal; Hongzhi Li; Charles Warden; Xueli Liu; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  Oncotarget       Date:  2018-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.